Filing Details
- Accession Number:
- 0001527715-20-000024
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-19 21:12:39
- Reporting Period:
- 2020-11-17
- Accepted Time:
- 2020-11-19 21:12:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1531048 | Inari Medical Inc. | NARI | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1190636 | M Steven Krausz | 1460 El Camino Real, Suite 100 Menlo Park CA 94025 | No | No | Yes | No | |
1192391 | Irwin Federman | 1460 El Camino Real, Suite 100 Menlo Park CA 94025 | No | No | Yes | No | |
1370817 | A Paul Matteucci | 1460 El Camino Real, Suite 100 Menlo Park CA 94025 | No | No | Yes | No | |
1440514 | Us Venture Partners X Lp | 1460 El Camino Real, Suite 100 Menlo Park CA 94025 | No | No | Yes | No | |
1453359 | Usvp X Affiliates Lp | 1460 El Camino Real, Suite 100 Menlo Park CA 94025 | No | No | Yes | No | |
1474322 | M Casey Tansey | 1460 El Camino Real, Suite 100 Menlo Park CA 94025 | No | No | Yes | No | |
1534399 | W. Richard Lewis | 1460 El Camino Real, Suite 100 Menlo Park CA 94025 | No | No | Yes | No | |
1602744 | Presidio Management Group X Llc | 1460 El Camino Real, Suite 100 Menlo Park CA 94025 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-11-17 | 2,245,605 | $0.00 | 5,239,744 | No | 4 | J | Indirect | Directly owned by USVP X |
Common Stock | Disposition | 2020-11-17 | 71,840 | $0.00 | 167,627 | No | 4 | J | Indirect | Directly owned by AFF X |
Common Stock | Acquisiton | 2020-11-17 | 587,851 | $0.00 | 587,851 | No | 4 | J | Indirect | Directly owned by PMG X |
Common Stock | Disposition | 2020-11-17 | 587,851 | $0.00 | 0 | No | 4 | J | Indirect | Directly owned by PMG X |
Common Stock | Acquisiton | 2020-11-17 | 37,268 | $0.00 | 37,268 | No | 4 | J | Indirect | Directly owned by Federman |
Common Stock | Acquisiton | 2020-11-17 | 60,883 | $0.00 | 60,883 | No | 4 | J | Indirect | Directly owned by Lewis |
Common Stock | Disposition | 2020-11-18 | 20,000 | $66.38 | 40,883 | No | 4 | S | Indirect | Directly owned by Lewis |
Common Stock | Acquisiton | 2020-11-17 | 56,173 | $0.00 | 56,173 | No | 4 | J | Indirect | Directly held by family trust controlled by Matteucci |
Common Stock | Acquisiton | 2020-11-17 | 67,730 | $0.00 | 67,730 | No | 4 | J | Indirect | Directly owned by Tansey |
Common Stock | Acquisiton | 2020-11-17 | 11,794 | $0.00 | 11,794 | No | 4 | J | Indirect | Directly held by family trust controlled by Krausz |
Common Stock | Acquisiton | 2020-11-17 | 34,576 | $0.00 | 34,576 | No | 4 | J | Indirect | Directly held by Krausz childrens trusts |
Common Stock | Acquisiton | 2020-11-17 | 34,576 | $0.00 | 34,576 | No | 4 | J | Indirect | Directly held by Krausz childrens trusts |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | J | Indirect | Directly owned by USVP X |
No | 4 | J | Indirect | Directly owned by AFF X |
No | 4 | J | Indirect | Directly owned by PMG X |
No | 4 | J | Indirect | Directly owned by PMG X |
No | 4 | J | Indirect | Directly owned by Federman |
No | 4 | J | Indirect | Directly owned by Lewis |
No | 4 | S | Indirect | Directly owned by Lewis |
No | 4 | J | Indirect | Directly held by family trust controlled by Matteucci |
No | 4 | J | Indirect | Directly owned by Tansey |
No | 4 | J | Indirect | Directly held by family trust controlled by Krausz |
No | 4 | J | Indirect | Directly held by Krausz childrens trusts |
No | 4 | J | Indirect | Directly held by Krausz childrens trusts |
Footnotes
- Represents a pro-rata in-kind distribution of the Issuer's common stock, and not a purchase or sale, without additional consideration to their respective partners, members and assignees, as applicable.
- Represents a pro-rata in-kind distribution of the Issuer's common stock held directly by each of U.S. Venture Partners X, L.P. ("USVP") and USVP X Affiliates Fund , L.P. ("AFF X" and, together with USVP X, the "USVP Funds", and may be deemed to have sole voting and dispositive power over the securities held by the USVP Funds. Jonathan Root, a director of the Issuer, Irwin Federman, Steven Krausz, Richard Lewis, Paul Matteucci, and Casey Tansey are the managing members of PMG X, who may be deemed to share voting and dispositive power over the reported securities held by the USVP X Funds, and disclaim beneficial ownership of such securities, except to the extent of any pecuniary interest therein.
- Represents a pro-rata in-kind distribution of the Issuer's common stock to PMG X from each of the USVP Funds, without additional consideration. Jonathan Root, a director of the Issuer, Irwin Federman, Steven Krausz, Richard Lewis, Paul Matteucci, and Casey Tansey are the managing members of PMG X, who may be deemed to share voting and dispositive power over the reported securities held by PMG X, and disclaim beneficial ownership of such securities, except to the extent of any pecuniary interest therein.
- Represents a pro-rata in-kind distribution of the Issuer's common stock held directly by PMG X, without additional consideration, to its members (the "PMG X Distribution"). Jonathan Root, a director of the Issuer, Irwin Federman, Steven Krausz, Richard Lewis, Paul Matteucci, and Casey Tansey are the managing members of PMG X, who may be deemed to share voting and dispositive power over the reported securities held by PMG X, and disclaim beneficial ownership of such securities, except to the extent of any pecuniary interest therein.
- Represents a change in the form of ownership from indirect to direct by virtue of the receipt of shares in the PMG X Distribution.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.52 to $67.32, inclusive for sales on 11/18/2020. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- Held by affiliated trusts for the benefit of Krausz children.